Results 1 to 5 of 28
Most popular |Most recent

Federal Court of Appeal provides course correction on the interpretation of pharmaceutical certificates of supplementary protection

Canada, European Union - April 27 2021 In 2017, Canada introduced its certificate of supplementary protection (CSP) regime, providing a form of patent term extension for pharmaceutical…

Nathaniel Lipkus, Rama Panford-Walsh.

Canadian courts are interpreting supplementary pharmaceutical patent protection more broadly than their EU counterparts

Canada, European Union - February 24 2021 For nearly 30 years, pharmaceutical patent policy in Canada has been designed to strike a balance between rewarding pharmaceutical innovation and…

Nathaniel Lipkus.

Choueifaty patent application found to possess patentable subject-matter

Canada - January 26 2021 As we previously reported, the Federal Court in Yves Choueifaty v Attorney General of Canada, 2020 FC 837 (Choueifaty) granted the appeal from the…

Geoffrey Langen, Nathaniel Lipkus.

2020: A year of clarity for Canadian life sciences and software patents

Canada - December 8 2020 Two industries in which patents play an undeniable strategic role are life sciences and software. Canada has historically been a strategic…

Lillian Wallace, Nathaniel Lipkus.

Canadian patent office issues guidance on computer-implemented and medical inventions following Choueifaty decision

Canada - November 10 2020 As we have previously reported, in the recent decision of the Federal Court in Yves Choueifaty v Attorney General of Canada, 2020 FC 837 (Choueifaty)…

Geoffrey Langen, Nathaniel Lipkus.